Literature DB >> 17633014

TRAF1 and its biological functions.

Soo Young Lee1, Yongwon Choi.   

Abstract

Tumor necrosis factor (TNF) receptor-associated factor (TRAF)1 was originally identified based on its ability to interact with the cytosolic domain ofTNF receptor type 2 (TNFR2). TRAF1 is unique among TRAF proteins in that it lacks RING domain found in the N-terminal regions of other TRAFs. TRAF1 can associate with multiple TNFR family members and can also bind several protein kinases and adaptor proteins suggesting that this protein likely possesses multiple functions in cytokine signaling networks. Although our understanding ofTRAF 1 functions and the underlying mechanisms at molecular and cellular levels has been advanced in recent years, much still needs to be learned before we have a full grasp of TRAF1 biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17633014     DOI: 10.1007/978-0-387-70630-6_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

1.  The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.

Authors:  Ali A Abdul-Sater; Maria I Edilova; Derek L Clouthier; Achire Mbanwi; Elisabeth Kremmer; Tania H Watts
Journal:  Nat Immunol       Date:  2016-11-28       Impact factor: 25.606

2.  Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.

Authors:  Chao Zheng; Venkataraman Kabaleeswaran; Yaya Wang; Genhong Cheng; Hao Wu
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

3.  TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.

Authors:  Hiroyuki Yamamoto; Joohyun Ryu; Eli Min; Naomi Oi; Ruihua Bai; Tatyana A Zykova; Dong Hoon Yu; Kenji Moriyama; Ann M Bode; Zigang Dong
Journal:  J Invest Dermatol       Date:  2017-01-25       Impact factor: 8.551

4.  According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.

Authors:  Elia Moreno-Cubero; Dolores Subirá; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid; Antonio Madejón; Joaquín Miquel; Antonio Olveira; Alejandro González-Praetorius; Javier García-Samaniego; Juan-Ramón Larrubia
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

5.  TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.

Authors:  Gema Pérez-Chacón; David Llobet; Constanza Pardo; José Pindado; Yongwon Choi; John C Reed; Juan M Zapata
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

6.  TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.

Authors:  Qingbing Meng; Minqian Zheng; Hongbing Liu; Changzhi Song; Wensheng Zhang; Juan Yan; Ling Qin; Xiaolan Liu
Journal:  Mol Cell Biochem       Date:  2012-08-12       Impact factor: 3.396

7.  TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.

Authors:  Qiushi Wang; Ge Gao; Tianshun Zhang; Ke Yao; Hanyong Chen; Mi Hee Park; Hiroyuki Yamamoto; Keke Wang; Weiya Ma; Margarita Malakhova; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2018-05-10       Impact factor: 12.701

8.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

9.  Protein interactions of the transcription factor Hoxa1.

Authors:  Barbara Lambert; Julie Vandeputte; Sophie Remacle; Isabelle Bergiers; Nicolas Simonis; Jean-Claude Twizere; Marc Vidal; René Rezsohazy
Journal:  BMC Dev Biol       Date:  2012-10-22       Impact factor: 1.978

10.  TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Authors:  Joanna Raszeja-Wyszomirska; Ewa Wunsch; Agnieszka Kempinska-Podhorodecka; Daniel S Smyk; Dimitrios P Bogdanos; Malgorzata Milkiewicz; Piotr Milkiewicz
Journal:  Clin Dev Immunol       Date:  2013-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.